Previous 10 | Next 10 |
Wall Street didn't have a good start to the week on Monday. Investors weren't happy to learn about massive explosions linked to a drone attack in Saudi Arabia, and fear about global energy supply sent crude oil prices soaring. That was good for energy stocks , but it made most market participan...
Aurora stock continues to move lower after an analyst at Stifel Nicolaus downgraded Aurora Cannabis (TSX:ACB) (NYSE:ACB) following last week’s disappointing earnings. Another Disappointment Over the past year or so, a few companies have firmly established themselves as the leader...
source: seeking alpha It's obvious that Aurora Cannabis ( ACB ) management jumped the gun in August when it gave guidance based upon unaudited data. The failure to meet its own guidance resulted in the appearance of vastly under performing, even though the numbers in the last reporting per...
ArQule (NASDAQ: ARQL ) initiated with Buy rating and $13 (63% upside) price target at H.C. Wainwright. More news on: ArQule, Inc., Esperion Therapeutics, Inc., Aurora Cannabis Inc., Healthcare stocks news, Stocks on the move, , Read more ...
During the past trading week (September 9 to 13), a Canadian producer missed on its previous earnings guidance, leading to a significant drop off in its shares. Comments from a former US federal regulator made headlines, while new developments in the hotly competitive cannabis-infused bevera...
Aurora Cannabis (NYSE: ACB) is doing everything it can to capture its share of the marijuana industry's torrid growth. The Canadian cannabis company has ramped up its production capabilities over the past year. It produced 57,442 kilograms of cannabis and sold 36,628 kilograms in fiscal 2...
Aurora Cannabis (NYSE: ACB) made the mistake with its fiscal 2019 fourth-quarter results that lots of businesses do: It overpromised and underdelivered. The Canadian cannabis producer missed its own revenue guidance provided just a few weeks ago and didn't achieve positive adjusted earning...
Since Canada began allowing recreational marijuana sales last October, Aurora Cannabis (NYSE: ACB) stock has fallen around 44% thanks to underwhelming sales and heavy operating losses. Recently released revenue results for the period ended June 30, 2019, disappointed analysts that ...
Image source: The Motley Fool. Aurora Cannabis Inc. (NYSE: ACB) Q4 2019 Earnings Call September 12, 2019, 9:00 a.m. ET Operator Continue reading
Aurora stock tumbled Thursday after releasing quarterly results that disappointed, and the downfall has continued into today. Aurora Cannabis (TSX:ACB) (NYSE:ACB), which is the second-largest cannabis company, spoke on the news, saying it’s still in demand, despite missing earnings...
News, Short Squeeze, Breakout and More Instantly...
The medical cannabis packaging market is undergoing rapid expansion, forecasted to catapult from $6.5 billion in 2023 to a staggering $117.2 billio...
A new survey has determined that about 25% of cannabis consumers use the drug to manage pain, with most revealing that they preferred fruity strains. The poll analyzed the responses of more than 6,500 consumers of cannabis who were asked questions on their preferences as well as their desired...
Lawmakers in Germany have set a maximum allowed limit of THC – the psychoactive substance found in the cannabis plant – for drivers to have...